19-50293703-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001145809.2(MYH14):c.5469+16C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.737 in 1,542,138 control chromosomes in the GnomAD database, including 424,673 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.66 ( 35484 hom., cov: 33)
Exomes 𝑓: 0.74 ( 389189 hom. )
Consequence
MYH14
NM_001145809.2 intron
NM_001145809.2 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -4.41
Publications
10 publications found
Genes affected
MYH14 (HGNC:23212): (myosin heavy chain 14) This gene encodes a member of the myosin superfamily. The protein represents a conventional non-muscle myosin; it should not be confused with the unconventional myosin-14 (MYO14). Myosins are actin-dependent motor proteins with diverse functions including regulation of cytokinesis, cell motility, and cell polarity. Mutations in this gene result in one form of autosomal dominant hearing impairment. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2011]
MYH14 Gene-Disease associations (from GenCC):
- autosomal dominant nonsyndromic hearing loss 4AInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics
- peripheral neuropathy-myopathy-hoarseness-hearing loss syndromeInheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- nonsyndromic genetic hearing lossInheritance: AD Classification: MODERATE Submitted by: ClinGen
- autosomal dominant nonsyndromic hearing lossInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 19-50293703-C-T is Benign according to our data. Variant chr19-50293703-C-T is described in ClinVar as Benign. ClinVar VariationId is 257578.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.901 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| MYH14 | NM_001145809.2 | c.5469+16C>T | intron_variant | Intron 39 of 42 | ENST00000642316.2 | NP_001139281.1 | ||
| MYH14 | NM_001077186.2 | c.5370+16C>T | intron_variant | Intron 38 of 41 | NP_001070654.1 | |||
| MYH14 | NM_024729.4 | c.5346+16C>T | intron_variant | Intron 37 of 40 | NP_079005.3 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.661 AC: 100501AN: 152014Hom.: 35464 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
100501
AN:
152014
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.754 AC: 149415AN: 198216 AF XY: 0.757 show subpopulations
GnomAD2 exomes
AF:
AC:
149415
AN:
198216
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.745 AC: 1035465AN: 1390006Hom.: 389189 Cov.: 41 AF XY: 0.746 AC XY: 509743AN XY: 683016 show subpopulations
GnomAD4 exome
AF:
AC:
1035465
AN:
1390006
Hom.:
Cov.:
41
AF XY:
AC XY:
509743
AN XY:
683016
show subpopulations
African (AFR)
AF:
AC:
12159
AN:
31626
American (AMR)
AF:
AC:
29639
AN:
35030
Ashkenazi Jewish (ASJ)
AF:
AC:
15314
AN:
21474
East Asian (EAS)
AF:
AC:
35425
AN:
38948
South Asian (SAS)
AF:
AC:
58582
AN:
74664
European-Finnish (FIN)
AF:
AC:
38954
AN:
50878
Middle Eastern (MID)
AF:
AC:
3909
AN:
5348
European-Non Finnish (NFE)
AF:
AC:
799947
AN:
1074786
Other (OTH)
AF:
AC:
41536
AN:
57252
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.460
Heterozygous variant carriers
0
12546
25092
37637
50183
62729
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
20046
40092
60138
80184
100230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.661 AC: 100560AN: 152132Hom.: 35484 Cov.: 33 AF XY: 0.669 AC XY: 49765AN XY: 74368 show subpopulations
GnomAD4 genome
AF:
AC:
100560
AN:
152132
Hom.:
Cov.:
33
AF XY:
AC XY:
49765
AN XY:
74368
show subpopulations
African (AFR)
AF:
AC:
16345
AN:
41468
American (AMR)
AF:
AC:
11827
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
AC:
2507
AN:
3472
East Asian (EAS)
AF:
AC:
4782
AN:
5182
South Asian (SAS)
AF:
AC:
3760
AN:
4824
European-Finnish (FIN)
AF:
AC:
8085
AN:
10584
Middle Eastern (MID)
AF:
AC:
211
AN:
294
European-Non Finnish (NFE)
AF:
AC:
51004
AN:
68000
Other (OTH)
AF:
AC:
1451
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1572
3145
4717
6290
7862
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
790
1580
2370
3160
3950
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2912
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:3
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jun 22, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Autosomal dominant nonsyndromic hearing loss 4A Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Peripheral neuropathy-myopathy-hoarseness-hearing loss syndrome Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.